Marketing, Licensing and Distribution Agreements - Vivus (Details)			6 Months Ended		12 Months Ended
	Jan. 18, 2022 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Marketing, Licensing and Distribution Agreements
Noncash decrease in accrued expenses related to Vivus settlement				$ (6,520,283)
Noncash decrease in API purchase commitment			$ 459,422	6,232,489
Noncash decrease in accrued inventory purchases related to Vivus Settlement				(14,203,905)
Gain on settlement with Vivus				3,389,941
API purchase commitment asset			684,053		$ 663,984
License Agreement | Royalty on the first $500 million of net sales
Marketing, Licensing and Distribution Agreements
Threshold net sales			500,000,000
License Agreement | Milestone payment to be paid once $250 million in sales has been reached
Marketing, Licensing and Distribution Agreements
Threshold net sales			250,000,000
Milestone payment			6,000,000
License Agreement | Milestone payment to be paid after $250 million in sales has been reached
Marketing, Licensing and Distribution Agreements
Threshold net sales			250,000,000
Milestone payment			$ 3,200,000
License Agreement | Vivus, Inc
Marketing, Licensing and Distribution Agreements
One-time fee to purchase and receive the license for the commercialization and exploitation of Stendra		$ 70,000,000
License Agreement | Vivus, Inc | Royalty during the first, second, and third years following the expiration of the Royalty Period
Marketing, Licensing and Distribution Agreements
Royalty percentage			2.00%
License Agreement | Vivus, Inc | Royalty following the fourth and fifth years following the end of the Royalty Period
Marketing, Licensing and Distribution Agreements
Royalty percentage			1.00%
License Agreement | MTPC
Marketing, Licensing and Distribution Agreements
Royalty incurred			$ 124,534	$ 242,847
Royalty receivable					106,115
License Agreement | MTPC | Royalty on the first $500 million of net sales
Marketing, Licensing and Distribution Agreements
Royalty percentage			5.00%
License Agreement | MTPC | Royalty on net sales after $500 million
Marketing, Licensing and Distribution Agreements
Royalty percentage			6.00%
Settlement Agreement | Vivus, Inc
Marketing, Licensing and Distribution Agreements
Inventory amount retained - API	$ 7,300,000
Prepayment amount	900,000
Noncash decrease in accrued expenses related to Vivus settlement	6,500,000
Noncash decrease in API purchase commitment	6,200,000
Noncash decrease in accrued inventory purchases related to Vivus Settlement	14,200,000
Payment made for purchase order	$ 1,542,904
Percentage of stendra tablets released	100
Gain on settlement with Vivus					3,400,000
Raw materials inventory			$ 700,000
Settlement Agreement | Vivus, Inc | Other Current Assets
Marketing, Licensing and Distribution Agreements
API purchase commitment asset			700,000		700,000
Settlement Agreement | Vivus, Inc | Other Noncurrent Assets
Marketing, Licensing and Distribution Agreements
Accrued inventory purchases, other assets			$ 4,700,000		$ 5,100,000
Settlement Agreement | Vivus, Inc | Promissory Note
Marketing, Licensing and Distribution Agreements
Prepayment amount	$ 900,000
Principal amount of notes payable	$ 10,201,758